Aptadir Therapeutics
A Milan-based biotech company developing novel treatments for difficult to treat genetic conditions.
Aptadir Therapeutics has raised €40M across 1 funding round from 5 investors, most recently a Seed round in Sep 2026. Based in Milan, Italy; active in Healthtech. Data as of 28 Oct 2026.
Milan, Italyaptadir.com ↗
Total raised
€40M
€39,630,119
Funding rounds
1
Investors
5
distinct backers
Active since
2026-09
latest 2026-09
Funding by year
EUR raised per year · 2026 YTDAptadir Therapeutics — funding by year — interactive chart.
Data table
| Aptadir Therapeutics — funding by year | |
|---|---|
| 2026 | €40M |
Signals
High confidenceRaise-next likelihood17
base rate 44% for Seed
- ▼ Raised very recently
- ▼ Low backer re-investment
Timing: too soon vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2026-09-29 | Seed | €40M | 4BIO Capital,CDP Venture Capital,CE Ventures,Extend,XGEN Venture | View deal → |
Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Bending Spoons€1.7BItaly · Software
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
Global coverage: FundingData